MOS vs CTVA vs SMG
161 measures in 16 categories, one definition each, computed from filings and market data.
MOS22.5
The Mosaic Company
Basic Materials · Agricultural Inputs
$18.82 −0.74%$6.0B mkt cap
Score DNA
SMG55.0
The Scotts Miracle-Gro Company
Basic Materials · Agricultural Inputs
$54.57 +0.59%$3.2B mkt cap
Score DNA
Price, rebased to 100 three years ago
MOS CTVA SMG · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | MOS | CTVA | SMG |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 1 | 2 | 0 |
| Last Congress purchase | 2026-07-07 | 2026-09-04 | — |
| 13F net change in holders | −27 | +17 | +24 |
| ETFs adding shares, 30d | 536 | 1,017 | 228 |
| ETFs trimming, 30d | 396 | 807 | 173 |
| Net ETF funds, 30d | +140 | +210 | +55 |
Valuation
16 measures| Measure | MOS | CTVA | SMG |
|---|---|---|---|
| P/E (TTM) | 138.5x
100th
|
8.5x
14th
|
42.9x
86th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | — | 1.66 | — |
| Price / sales | 0.5x
25th
|
0.5x
12th
|
0.9x
50th
|
| Price / book | 0.5x
29th
|
0.3x
0th
|
— |
| Price / tangible book | 0.6x
0th
|
8.5x
100th
|
— |
| Price / free cash flow | — | 13.7x
57th
|
9.7x
43rd
|
| Price / operating cash flow | 13.5x
100th
|
7.1x
62nd
|
8.6x
88th
|
| Enterprise value | $11.5B
75th
|
$11.1B
62nd
|
$5.3B
38th
|
| EV / sales | 1.0x
25th
|
0.6x
0th
|
1.6x
62nd
|
| EV / EBITDA | 5.8x
43rd
|
3.4x
0th
|
11.6x
100th
|
| EV / EBIT | 13.3x
71st
|
5.5x
0th
|
14.9x
86th
|
| EV / free cash flow | — | 17.7x
57th
|
16.1x
43rd
|
| Earnings yield | 0.7%
12th
|
11.7%
88th
|
2.3%
25th
|
| FCF yield | -15.8%
0th
|
7.3%
50th
|
10.3%
62nd
|
| Operating cash flow yield | 7.4%
0th
|
14.1%
38th
|
11.6%
12th
|
| Graham number (per share) | $10.50
17th
|
$35.59
33rd
|
— |
Profitability (TTM)
12 measures| Measure | MOS | CTVA | SMG |
|---|---|---|---|
| Gross margin | 11.5%
0th
|
48.5%
100th
|
32.3%
62nd
|
| EBITDA margin | 16.6%
25th
|
18.2%
50th
|
13.5%
12th
|
| Operating margin | 1.4%
12th
|
16.8%
75th
|
12.3%
50th
|
| EBIT margin | 7.3%
25th
|
11.2%
62nd
|
10.4%
38th
|
| Net margin | 0.4%
12th
|
5.7%
50th
|
2.2%
25th
|
| NOPAT margin | 0.4%
12th
|
11.6%
75th
|
7.7%
50th
|
| FCF margin | -8.0%
0th
|
3.5%
12th
|
9.7%
62nd
|
| Operating cash flow margin | 3.7%
0th
|
6.8%
25th
|
10.9%
38th
|
| R&D / revenue | 0.0%
0th
|
8.4%
100th
|
0.5%
62nd
|
| SG&A / revenue | 4.2%
0th
|
20.4%
88th
|
16.0%
62nd
|
| Stock comp / revenue | 0.3%
29th
|
0.0%
0th
|
1.8%
100th
|
| Effective tax rate | 72.2%
100th
|
30.7%
62nd
|
37.2%
88th
|
Returns on capital
11 measures| Measure | MOS | CTVA | SMG |
|---|---|---|---|
| ROE (on average equity) | 0.4%
14th
|
4.0%
29th
|
— |
| ROA | 0.2%
12th
|
2.4%
50th
|
2.4%
25th
|
| ROIC | 0.3%
12th
|
7.5%
50th
|
13.9%
75th
|
| ROCE | 4.2%
25th
|
6.5%
38th
|
17.1%
75th
|
| Return on tangible assets | 3.5%
25th
|
4.8%
38th
|
11.3%
75th
|
| Cash ROIC (OCF / invested capital) | 2.6%
12th
|
4.4%
25th
|
19.7%
75th
|
| Gross profitability (GP / assets) | 5.6%
0th
|
20.3%
75th
|
34.4%
100th
|
| ROIC, 3-yr average | 0.8%
25th
|
4.5%
75th
|
2.5%
38th
|
| ROIC, 5-yr average | 8.1%
43rd
|
5.3%
29th
|
— |
| ROE, 5-yr average | 11.0%
43rd
|
4.6%
29th
|
— |
| Incremental ROIC | -83.2%
14th
|
221.4%
71st
|
-201.5%
0th
|
Growth
17 measures| Measure | MOS | CTVA | SMG |
|---|---|---|---|
| Revenue growth (TTM YoY) | 5.5%
50th
|
3.7%
25th
|
-2.0%
12th
|
| Revenue growth (QoQ) | -5.8%
25th
|
30.1%
88th
|
-19.7%
12th
|
| Revenue CAGR, 3 yr | -11.0%
12th
|
0.5%
100th
|
-2.8%
75th
|
| Revenue CAGR, 5 yr | 3.6%
25th
|
3.7%
38th
|
-7.9%
0th
|
| Gross profit CAGR, 3 yr | -28.2%
0th
|
5.4%
88th
|
19.2%
100th
|
| Operating income CAGR, 3 yr | -60.8%
0th
|
14.2%
86th
|
185.6%
100th
|
| Net income growth (TTM YoY) | -95.4%
0th
|
-28.0%
17th
|
39.4%
50th
|
| Net income CAGR, 3 yr | -72.9%
0th
|
3.0%
100th
|
— |
| EPS growth (TTM YoY) | -95.4%
0th
|
-26.7%
17th
|
38.2%
50th
|
| EPS CAGR, 3 yr | -72.5%
0th
|
5.1%
100th
|
— |
| EPS CAGR, 5 yr | -48.3%
0th
|
-1.7%
50th
|
-33.8%
17th
|
| FCF growth (TTM YoY) | — | -75.8%
0th
|
33.4%
100th
|
| FCF CAGR, 3 yr | — | — | -10.7%
80th
|
| Operating cash flow CAGR, 3 yr | -47.5%
0th
|
— | -12.2%
57th
|
| Book value CAGR, 3 yr | -1.0%
29th
|
0.7%
57th
|
— |
| Dividend CAGR, 3 yr | 2.3%
43rd
|
3.3%
57th
|
13.1%
86th
|
| Sustainable growth rate | -2.0%
0th
|
2.1%
33rd
|
— |
Margin history & stability
7 measures| Measure | MOS | CTVA | SMG |
|---|---|---|---|
| Gross margin, 3-yr average | 13.8%
0th
|
45.7%
100th
|
28.2%
38th
|
| Operating margin, 3-yr average | 5.1%
25th
|
14.8%
75th
|
7.0%
38th
|
| Net margin, 3-yr average | 3.6%
38th
|
6.4%
75th
|
-1.2%
25th
|
| FCF margin, 3-yr average | -1.4%
0th
|
9.2%
50th
|
15.1%
75th
|
| Revenue stability (0-1) | 0.00
0th
|
0.70
88th
|
0.79
100th
|
| Earnings stability (0-1) | 0.48
100th
|
0.11
50th
|
0.08
25th
|
| Margin stability (0-1) | 0.75
38th
|
0.93
100th
|
0.77
50th
|
Liquidity (latest quarter)
7 measures| Measure | MOS | CTVA | SMG |
|---|---|---|---|
| Cash & short-term investments | $294.0M
38th
|
$2.4B
88th
|
$27.7M
0th
|
| Net cash (− = net debt) | −$5.6B
12th
|
−$2.5B
50th
|
−$2.1B
62nd
|
| Working capital | $1.4B
38th
|
$5.6B
100th
|
$238.3M
12th
|
| Current ratio | 1.34
12th
|
1.52
38th
|
1.21
0th
|
| Quick ratio | 0.43
0th
|
1.10
50th
|
0.78
12th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.07
12th
|
0.22
50th
|
0.02
0th
|
| Defensive interval (days) | 435 days
25th
|
736 days
50th
|
401 days
12th
|
Leverage & solvency (latest quarter)
13 measures| Measure | MOS | CTVA | SMG |
|---|---|---|---|
| Total debt | $5.9B
88th
|
$4.9B
75th
|
$2.1B
25th
|
| Debt / equity | 0.51
43rd
|
0.19
14th
|
— |
| Net debt / equity | 0.49
71st
|
0.10
14th
|
— |
| Debt / assets | 23.8%
25th
|
11.7%
12th
|
66.7%
100th
|
| Debt / capital | 33.8%
43rd
|
16.2%
14th
|
— |
| Debt / EBITDA | 2.97
86th
|
1.50
29th
|
4.66
100th
|
| Net debt / EBITDA | 2.82
86th
|
0.77
29th
|
4.59
100th
|
| Interest coverage (EBIT / interest) | 3.8x
38th
|
11.4x
62nd
|
3.1x
25th
|
| Cash interest coverage | 2.0x
12th
|
6.9x
62nd
|
3.3x
38th
|
| Debt payback (years of OCF) | 13.2 yrs
88th
|
4.0 yrs
62nd
|
5.7 yrs
75th
|
| Liabilities / assets | 52.8%
62nd
|
39.0%
12th
|
106.6%
100th
|
| IS credit model rating | BB | A | B- |
| Implied credit spread (bps) | 475
75th
|
150
25th
|
900
100th
|
Efficiency
11 measures| Measure | MOS | CTVA | SMG |
|---|---|---|---|
| Asset turnover | 0.49
38th
|
0.43
12th
|
1.08
100th
|
| Fixed asset turnover | 0.87
0th
|
1.83
75th
|
5.31
88th
|
| Inventory turnover | 3.1
50th
|
2.1
12th
|
4.5
75th
|
| Receivables turnover | 12.0
88th
|
2.2
12th
|
5.2
50th
|
| Days sales outstanding | 30 days
12th
|
164 days
88th
|
70 days
50th
|
| Days inventory outstanding | 117 days
50th
|
171 days
88th
|
82 days
25th
|
| Days payables outstanding | 42 days
25th
|
152 days
100th
|
46 days
38th
|
| Cash conversion cycle (days) | 105 days
25th
|
183 days
88th
|
106 days
38th
|
| Capex / revenue | 11.7%
86th
|
3.3%
14th
|
1.3%
0th
|
| Capex / depreciation | 1.26
100th
|
0.47
14th
|
0.42
0th
|
| Operating expense ratio | 8.9%
25th
|
24.3%
88th
|
16.7%
50th
|
Cash flow & earnings quality
7 measures| Measure | MOS | CTVA | SMG |
|---|---|---|---|
| Operating cash flow / net income | 10.28
100th
|
1.20
0th
|
4.99
86th
|
| FCF / net income | −21.92
0th
|
0.62
14th
|
4.41
100th
|
| FCF / operating cash flow | -213.3%
0th
|
51.9%
57th
|
88.4%
100th
|
| Capex / operating cash flow | 313.3%
100th
|
48.1%
43rd
|
11.6%
0th
|
| Accruals ratio | -1.6%
88th
|
-0.5%
100th
|
-9.4%
12th
|
| Sloan accruals ratio | -1.4%
62nd
|
-5.2%
25th
|
-11.1%
0th
|
| Earnings quality score (0-1) | 1.00
71st
|
1.00
71st
|
0.75
0th
|
Scores & forensic checks
15 measures| Measure | MOS | CTVA | SMG |
|---|---|---|---|
| IS score | 23
12th
|
41
25th
|
55
50th
|
| IS profitability | 3
0th
|
54
75th
|
28
25th
|
| IS growth | 24
25th
|
23
12th
|
66
75th
|
| IS value | 54
38th
|
39
12th
|
32
0th
|
| IS momentum | 58
25th
|
56
12th
|
84
50th
|
| IS risk (safety) | 30
12th
|
65
75th
|
50
25th
|
| IS quality | 60
25th
|
75
50th
|
57
12th
|
| IS balance sheet | 53
25th
|
73
75th
|
23
0th
|
| IS earnings quality | 87
100th
|
73
50th
|
60
12th
|
| IS cash flow | 25
0th
|
33
25th
|
67
75th
|
| Piotroski F-score (0-9) | 6
38th
|
5
0th
|
5
0th
|
| Altman Z-score | 1.7
12th
|
2.9
88th
|
2.4
50th
|
| Beneish M-score | −1.98
100th
|
−2.61
38th
|
−2.69
25th
|
| Ohlson O-score | −7.49
62nd
|
−9.17
25th
|
−5.90
88th
|
| IS credit score | 40
25th
|
74
75th
|
20
0th
|
Size (TTM)
8 measures| Measure | MOS | CTVA | SMG |
|---|---|---|---|
| Market cap | $6.0B
50th
|
$8.6B
75th
|
$3.2B
38th
|
| Revenue | $11.9B
75th
|
$17.8B
88th
|
$3.4B
38th
|
| EBITDA | $2.0B
62nd
|
$3.2B
75th
|
$453.9M
38th
|
| Net income | $43.2M
25th
|
$1.0B
75th
|
$74.0M
38th
|
| Free cash flow | −$947.1M
0th
|
$629.0M
75th
|
$326.4M
62nd
|
| Total assets | $24.6B
75th
|
$41.6B
88th
|
$3.2B
25th
|
| Shareholders' equity | $11.5B
75th
|
$25.2B
88th
|
−$208.7M
0th
|
| Employees | 13,249
75th
|
21,500
88th
|
5,200
38th
|
Price performance
9 measures| Measure | MOS | CTVA | SMG |
|---|---|---|---|
| 1 day | −0.7% | 0.0% | +0.6% |
| 1 week | +0.4% | −2.7% | +9.4% |
| 1 month | −25.9% | −84.2% | +1.2% |
| 3 months | −16.1% | −85.2% | −20.4% |
| 6 months | −23.4% | −84.0% | −15.5% |
| Year to date | −24.8% | −81.0% | −5.2% |
| 1 year | −36.3% | −79.1% | +3.3% |
| 3 years, cumulative | −44.4% | −73.5% | +27.4% |
| 5 years, cumulative | −48.6% | −68.5% | −54.8% |
Technicals
4 measures| Measure | MOS | CTVA | SMG |
|---|---|---|---|
| RSI 14 | 26.4 | 11.4 | 57.7 |
| From 52-week high | −41.7% | −85.8% | −26.8% |
| From 52-week low | +2.2% | +12.2% | +13.9% |
| Beta | 0.83 | 0.58 | 1.85 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17